{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:27:59Z","timestamp":1757626079606,"version":"3.44.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82272864"],"award-info":[{"award-number":["No. 82272864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06990-6","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:19:45Z","timestamp":1756372785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics"],"prefix":"10.1186","volume":"23","author":[{"given":"Fan","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziteng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangge","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-0965","authenticated-orcid":false,"given":"Hao","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"3","key":"6990_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"6990_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eururo.2024.07.019","volume":"87","author":"RCA Leenen","year":"2025","unstructured":"Leenen RCA, Venderbos LDF, Helleman J, et al. Prostate cancer early detection in the European Union and UK. Eur Urol. 2025;87(3):326\u201339.","journal-title":"Eur Urol"},{"issue":"26","key":"6990_CR3","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/JCO.23.00433","volume":"41","author":"C Dai","year":"2023","unstructured":"Dai C, Dehm SM, Sharifi N. Targeting the androgen signaling axis in prostate cancer. J Clin Oncol. 2023;41(26):4267\u201378.","journal-title":"J Clin Oncol"},{"issue":"3","key":"6990_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2023.03.038","volume":"84","author":"N Beije","year":"2023","unstructured":"Beije N, Abida W, Antonarakis ES, et al. PARP inhibitors for prostate cancer: tangled up in profound and propel (and TALAPRO-2) blues. Eur Urol. 2023;84(3):253\u20136.","journal-title":"Eur Urol"},{"issue":"1","key":"6990_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-024-09984-0","volume":"41","author":"X Wu","year":"2025","unstructured":"Wu X, Zhang X, Tang S, et al. The important role of the histone acetyltransferases p300\/CBP in cancer and the promising anticancer effects of p300\/CBP inhibitors. Cell Biol Toxicol. 2025;41(1): 32.","journal-title":"Cell Biol Toxicol"},{"issue":"7779","key":"6990_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"6","key":"6990_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114308","volume":"43","author":"C De S\u00e1 Fernandes","year":"2024","unstructured":"De S\u00e1 Fernandes C, Novoszel P, Gastaldi T, et al. The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity. Cell Rep. 2024;43(6): 114308.","journal-title":"Cell Rep"},{"key":"6990_CR8","doi-asserted-by":"crossref","unstructured":"Li C-H, Liang S-B, Huang Q-W et al. Minor Spliceosomal 65K\/RNPC3 Interacts with ANKRD11 and Mediates HDAC3-Regulated Histone Deacetylation and Transcription[J]. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2024, 11(29): e2307804.","DOI":"10.1002\/advs.202307804"},{"issue":"1","key":"6990_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23(1): 90.","journal-title":"Mol Cancer"},{"issue":"1","key":"6990_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"issue":"21","key":"6990_CR11","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, et al. H3k18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 2024;84(21):3589\u2013601.","journal-title":"Cancer Res"},{"issue":"10","key":"6990_CR12","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024:187(10):2375\u20132392.e33. https:\/\/doi.org\/10.1016\/j.cell.2024.04.002","journal-title":"Cell"},{"issue":"8021","key":"6990_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, Li Y, Li H, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u20139.","journal-title":"Nature"},{"issue":"1","key":"6990_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0613-z","volume":"16","author":"G Ma","year":"2017","unstructured":"Ma G, Liu H, Hua Q, et al. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Mol Cancer. 2017;16(1): 46.","journal-title":"Mol Cancer"},{"issue":"2","key":"6990_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020245","volume":"11","author":"MS Basile","year":"2019","unstructured":"Basile MS, Fagone P, Mangano K, et al. KCNMA1 expression is downregulated in colorectal cancer via epigenetic mechanisms. Cancers (Basel). 2019;11(2): 245.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"6990_CR16","doi-asserted-by":"publisher","first-page":"C1050","DOI":"10.1152\/ajpcell.00287.2013","volume":"306","author":"IM Hdud","year":"2014","unstructured":"Hdud IM, Mobasheri A, Loughna PT. Effect of osmotic stress on the expression of TRPV4 and BKCa channels and possible interaction with ERK1\/2 and p38 in cultured equine chondrocytes[J]. Am J Physiol Cell Physiol. 2014;306(11):C1050\u20137.","journal-title":"Am J Physiol Cell Physiol"},{"key":"6990_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-258","volume":"9","author":"D Khaitan","year":"2009","unstructured":"Khaitan D, Sankpal UT, Weksler B, et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer. 2009;9: 258.","journal-title":"BMC Cancer"},{"issue":"4","key":"6990_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten M, Barbacid M. Targeting the MAPK pathway in KRAS-driven tumors. Cancer Cell. 2020;37(4):543\u201350.","journal-title":"Cancer Cell"},{"issue":"1","key":"6990_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1): 455.","journal-title":"Signal Transduct Target Ther"},{"issue":"D1","key":"6990_CR20","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol Y, Bandla C, Kundu DJ, et al. The PRIDE database at 20 years: 2025 update[J]. Nucleic Acids Res. 2025;53(D1):D543\u201353.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6990_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"6990_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12: 687975.","journal-title":"Front Immunol"},{"issue":"D1","key":"6990_CR23","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment[J]. Nucleic Acids Res. 2023;51(D1):D1425\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6990_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41580-018-0094-y","volume":"20","author":"E Lundberg","year":"2019","unstructured":"Lundberg E, Borner GHH. Spatial proteomics: a powerful discovery tool for cell biology. Nat Rev Mol Cell Biol. 2019;20(5):285\u2013302.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"D1","key":"6990_CR25","doi-asserted-by":"publisher","first-page":"D274","DOI":"10.1093\/nar\/gkaa1018","volume":"49","author":"MY Galperin","year":"2021","unstructured":"Galperin MY, Wolf YI, Makarova KS, et al. COG database update: focus on microbial diversity, model organisms, and widespread pathogens[J]. Nucleic Acids Res. 2021;49(D1):D274\u201381.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"6990_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15041","volume":"33","author":"SX Tan","year":"2024","unstructured":"Tan SX, Chong S, Rowe C, et al. Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma. Exp Dermatol. 2024;33(3): e15041.","journal-title":"Exp Dermatol"},{"issue":"2","key":"6990_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.intimp.2014.06.040","volume":"22","author":"L Ge","year":"2014","unstructured":"Ge L, Hoa NT, Wilson Z, et al. Big potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. Int Immunopharmacol. 2014;22(2):427\u201343.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6990_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","volume":"13","author":"J Yuan","year":"2020","unstructured":"Yuan J, Dong X, Yap J, et al. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol. 2020;13(1):113.","journal-title":"J Hematol Oncol"},{"key":"6990_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-cancerbio-062822-030450","volume":"8","author":"DA Bonsor","year":"2024","unstructured":"Bonsor DA, Simanshu DK. RAS and SHOC2 roles in RAF activation and therapeutic considerations. Annu Rev Cancer Biol. 2024;8:97\u2013113. https:\/\/doi.org\/10.1146\/annurev-cancerbio-062822-030450","journal-title":"Annu Rev Cancer Biol"},{"issue":"3","key":"6990_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, et al. Targeting the warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B. 2024;14(3):953\u20131008. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.003","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"6990_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15(1): 160.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"6990_CR32","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.7150\/thno.104858","volume":"15","author":"C Sun","year":"2025","unstructured":"Sun C, Li X, Teng Q, et al. Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics. 2025;15(7):3055\u201375.","journal-title":"Theranostics"},{"issue":"Pt B","key":"6990_CR33","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","volume":"222","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang Z, Yu Y, et al. HIF1\u03b1 lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer[J]. Int J Biol Macromol. 2022;222(Pt B):2225\u201343.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"6990_CR34","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/mas.21781","volume":"42","author":"RB Kitata","year":"2023","unstructured":"Kitata RB, Yang J-C, Chen Y-J. Advances in data-independent acquisition mass spectrometry towards comprehensive digital proteome landscape. Mass Spectrom Rev. 2023;42(6):2324\u201348.","journal-title":"Mass Spectrom Rev"},{"issue":"38","key":"6990_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406333","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen J, Zhao D, Wang Y, et al. Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis. Adv Sci. 2024;11(38): e2406333.","journal-title":"Adv Sci"},{"issue":"11","key":"6990_CR36","doi-asserted-by":"publisher","first-page":"e202308099","DOI":"10.1083\/jcb.202308099","volume":"223","author":"Y Huang","year":"2024","unstructured":"Huang Y, Luo G, Peng K, et al. Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 2024;223(11):e202308099. https:\/\/doi.org\/10.1083\/jcb.202308099","journal-title":"J Cell Biol"},{"issue":"47","key":"6990_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406026","volume":"11","author":"F Ouyang","year":"2024","unstructured":"Ouyang F, Li Y, Wang H, et al. Aloe emodin alleviates radiation-induced heart disease via blocking P4HB lactylation and mitigating kynurenine metabolic disruption. Adv Sci. 2024;11(47): e2406026.","journal-title":"Adv Sci"},{"issue":"1","key":"6990_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.gendis.2022.04.025","volume":"10","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhao Y, Zha L, et al. KCNMA1 promotes obesity-related hypertension: integrated analysis based on genome-wide association studies. Genes Dis. 2023;10(1):58\u201361.","journal-title":"Genes Dis"},{"key":"6990_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-51","volume":"4","author":"H Jiao","year":"2011","unstructured":"Jiao H, Arner P, Hoffstedt J, et al. Genome wide association study identifies KCNMA1 contributing to human obesity. BMC Med Genomics. 2011;4: 51.","journal-title":"BMC Med Genomics"},{"issue":"D1","key":"6990_CR40","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","volume":"49","author":"M Martens","year":"2021","unstructured":"Martens M, Ammar A, Riutta A, et al. WikiPathways: connecting communities[J]. Nucleic Acids Res. 2021;49(D1):D613\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6990_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46811-w","volume":"15","author":"A Bulle","year":"2024","unstructured":"Bulle A, Liu P, Seehra K, et al. Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer. Nat Commun. 2024;15(1): 2503.","journal-title":"Nat Commun"},{"issue":"7","key":"6990_CR42","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.CD-24-0139","volume":"14","author":"MB Ryan","year":"2024","unstructured":"Ryan MB, Quade B, Schenk N, et al. The Pan-RAF-MEK nondegrading molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers. Cancer Discov. 2024;14(7):1190\u2013205.","journal-title":"Cancer Discov"},{"issue":"2","key":"6990_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/cas.16040","volume":"115","author":"X Sun","year":"2024","unstructured":"Sun X, Zhang Y, Xin S, et al. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway. Cancer Sci. 2024;115(2):412\u201326.","journal-title":"Cancer Sci"},{"key":"6990_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154794","volume":"114","author":"H Kim","year":"2023","unstructured":"Kim H, Hwang B, Cho S, et al. The ethanol extract of Cyperus exaltatus var. Iwasakii exhibits cell cycle dysregulation, ERK1\/2\/p38 MAPK\/AKT phosphorylation, and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo. Phytomedicine. 2023;114: 154794.","journal-title":"Phytomedicine"},{"key":"6990_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216726","volume":"588","author":"M Gao","year":"2024","unstructured":"Gao M, Shi J, Xiao X, et al. PD-1 regulation in immune homeostasis and immunotherapy. Cancer Lett. 2024;588: 216726.","journal-title":"Cancer Lett"},{"issue":"5","key":"6990_CR46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/JCO.19.01638","volume":"38","author":"ES Antonarakis","year":"2020","unstructured":"Antonarakis ES, Piulats JM, Gross-Goupil M, et al. Pembrolizumab for Treatment-Refractory metastatic Castration-Resistant prostate cancer: multicohort, Open-Label phase II KEYNOTE-199 Study. J Clin Oncol. 2020;38(5):395\u2013405.","journal-title":"J Clin Oncol"},{"issue":"1","key":"6990_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2022.12.003","volume":"56","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ji L, Li MO. Control of tumor-associated macrophage responses by nutrient acquisition and metabolism. Immunity. 2023;56(1):14\u201331.","journal-title":"Immunity"},{"issue":"11","key":"6990_CR48","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41423-024-01216-z","volume":"21","author":"A Mantovani","year":"2024","unstructured":"Mantovani A, Marchesi F, Di Mitri D, et al. Macrophage diversity in cancer dissemination and metastasis. Cell Mol Immunol. 2024;21(11):1201\u201314.","journal-title":"Cell Mol Immunol"},{"issue":"17","key":"6990_CR49","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1038\/sj.onc.1210036","volume":"26","author":"M Bloch","year":"2007","unstructured":"Bloch M, Ousingsawat J, Simon R, et al. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene. 2007;26(17):2525\u201334.","journal-title":"Oncogene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06990-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06990-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06990-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:52:57Z","timestamp":1757451177000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06990-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6990"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06990-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethics committee of Beijing Tongren Hospital, Capital Medical University and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This paper was published with the consent of all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"No conflict of interest exists in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"967"}}